Sfoglia per Autore
Shortened and intensified MJMA: an effective salvage therapy for relapsed and refractory lymphomas and a strong mobilizer of PBSCs.
2009-01-01 Gobbi, Paolo; Valentino, Francesco; Lambelet, P; Perfetti, V; Bergamaschi, Gaetano; Girino, M; Corazza, GINO ROBERTO
Complete long-term response to radiotherapy of gastric early-stage marginal zone lymphoma resistant to both anti-Helicobacter pylori antibiotics and chemotherapy.
2009-01-01 Gobbi, Paolo; Corbella, F; Valentino, Francesco; Bergonzi, M; Sangalli, C; Perfetti, V; Corazza, GINO ROBERTO
International prognostic scoring system for Waldenstrom macroglobulinemia.
2009-01-01 Morel, P; Duhamel, A; Gobbi, Paolo; Dimopoulos, Ma; Dhodapkar, Mv; Mccoy, J; Crowley, J; Ocio, Em; Garcia Sanz, R; Treon, Sp; Leblond, V; Kyle, Ra; Barlogie, B; Merlini, Giampaolo
International prognostic scoring system for Waldenstrom macroglobulinemia
2009-01-01 P., Morel; A., Duhamel; Gobbi, Paolo; M. A., Dimopoulos; M. V., Dhodapkar; J., Mccoy; J., Crowley; E. M., Ocio; R., Garcia Sanz; S. P., Treon; V., Leblond; R. A., Kyle; B., Barlogie; Merlini, Giampaolo
Long-term outcome of patients with localized aggressive non-Hodgkin lymphoma treated with ProMECE-CytaBOM plus involved-field radiation therapy: a study of the Gruppo Italiano Studio Linfomi.
2010-01-01 Mannina, D.; Luminari, S.; Dondi, A.; Polimeno, G.; Baldini, L.; Stelitano, C.; Merli, F.; Dell’Olio, M.; Gobbi, Paolo; Giglio, G.; Barbolini, E.; Brugiatelli, M.; Federico, M.
Chemoresistance as a function of the pre-therapy tumor burden and the chemotherapy regimen administered. Differences observed with two current chemotherapy regimens for advanced Hodgkin lymphoma
2011-01-01 Gobbi, Paolo; Valentino, Francesco; Bassi, E.; Coriani, C.; Merli, F.; Bonfante, V.; Marchianò, A.; Gallamini, A.; Bolis, S.; Stelitano, C.; Levis, A.; Federico, M.; Angrilli, F.; Di Giulio, G.; Corazza, GINO ROBERTO
Pamidronate versus observation in asymptomatic myeloma: final results with long follow-up of a randomized study
2011-01-01 D’Arena, G.; Gobbi, Paolo; Broglia, CHIARA MARIA GIOVANNA; Sacchi, S.; Quarta, G.; Baldini, L.; Iannitto, E.; Falcone, A.; Guariglia, R.; Pietrantuono, G.; Villani, O.; Martonelli, M. C.; Mansueto, G.; Sanpaolo, G.; Cascavilla, N.; Musto, P.
Long-term follow-up analysis of HD9601 trial comparing ABVD vs. Stanford V vs. MOPPEBVCAD in patients with newly diagnosed advanced-stage Hodgkin lymphoma. A study from the Intergruppo Italiano Linfomi (IIL).
2011-01-01 Chisesi, T.; Bellei, M.; Luminari, S.; Montanini, A.; Marcheselli, L.; Levis, A.; Gobbi, Paolo; Vitolo, U.; Stelitano, C.; Pavone, V.; Merli, F.; Liberati, M.; Baldini, L.; Bordonaro, R.; Pesce, E. A.; Federico, M.
Improving the AJCC/TNM Classification for use in early gastric cancer
2011-01-01 Gobbi, Paolo; Villano, L.; Pozzoli, D.; Bergonzi, Manuela; Vanoli, Alessandro; Tava, Francesca; Dionigi, Paolo; Corazza, GINO ROBERTO
Tumor burden at diagnosis is the main clinical predictor of cell resistance in patients with early-stage, favorable Hodgkin lymphoma treated with VBM chemotherapy plus radiotherapy.
2012-01-01 Gobbi, Paolo; Bergonzi, Manuela; Bassi, E.; Merli, F.; Coriani, C.; Federico, M.
R-CHOP vs. R-mini-CEOP for the initial treatment of elderly “fit” patients with diffuse large B-cell lymphoma. Results from the ANZINTER3 trial of the Intergruppo Italiano Linfomi (IIL).
2012-01-01 Merli, F.; Luminari, S.; Rossi, G.; Mammi, C.; Marcheselli, L.; Tucci, A.; Ilariucci, F.; Chiappella, A.; Musso, M.; Di Rocco, A.; Stelitano, C.; Alvarez, I.; Baldini, L.; Mazza, P.; Salvi, F.; Arcari, A.; Fragasso, A.; Gobbi, Paolo; Liberati, A. M.; Federico, M.
Tumor burden in Hodgkin's lymphoma can be reliably estimated from a few staging parameters
2012-01-01 Gobbi, Paolo; Bergonzi, E.; Bassi, E.; Merli, F.; Coriani, C.; Stelitano, C.; Iannitto, E.; Federico, M.
Role of glutathione-S-transferase (GST) polymorphisms in patients with advanced Hodgkin lymphoma: results from the HD2000 GISL trial.
2012-01-01 Morabito, F.; Hohaus, S.; Mammi, C.; Marcheselli, L; . Gentile M, .; Merli, F.; Montanini, A.; Stelitano, C.; La Sala, A.; Scalone, R.; Voso, M. T.; Luminari, S.; Iannitto, E.; Gobbi, Paolo; Federico, M.
Tumor burden predicts treatment resistance in patients with early unfavorable or advanced-stage Hodgkin Lymphoma treated with ABVD and radiotherapy.
2012-01-01 Gobbi, Paolo; Bassi, E.; Bergonzi, E.; Merli, F.; Coriani, C.; Iannitto, E.; Luminari, S.; Polimeno, G.; Federico, M.
How I treat enteropathy-associated T-cell lymphoma
2012-01-01 DI SABATINO, Antonio; Biagi, Federico; Gobbi, Paolo; Corazza, GINO ROBERTO
What has happened to VBM (vinblastine, bleomycin and methotrexate) chemotherapy for early-stage Hodgkin lymphoma ?
2012-01-01 Gobbi, Paolo; Federico, M.
Hodgkin lymphoma.
2013-01-01 Gobbi, Paolo; Ferreri, A. J.; Ponzoni, M.; Levis, A.
The prognostic role of time to diagnosis and presenting symptoms in patients with pancreatic cancer
2013-01-01 Gobbi, Paolo; M., Bergonzi; Comelli, MARIO ANGELO; L., Villano; D., Pozzoli; Vanoli, Alessandro; Dionigi, Paolo
Medication prescription and adherence disparities in non valvular atrial fibrillation patients: an Italian portrait from the ARAPACIS study
2014-01-01 Raparelli, Valeria; Proietti, Marco; Buttà, Carmelo; Di Giosia, Paolo; Sirico, Domenico; Gobbi, Paolo; Corrao, Salvatore; Davì, Giovanni; Vestri, Anna Rita; Perticone, Francesco; Corazza, GINO ROBERTO; Violi, Francesco; Basili, Stefania
Tumor burden in Hodgkin’s lymphoma: much more than the best prognostic factor.
2014-01-01 Gobbi, Paolo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Shortened and intensified MJMA: an effective salvage therapy for relapsed and refractory lymphomas and a strong mobilizer of PBSCs. | 1-gen-2009 | Gobbi, Paolo; Valentino, Francesco; Lambelet, P; Perfetti, V; Bergamaschi, Gaetano; Girino, M; Corazza, GINO ROBERTO | |
| Complete long-term response to radiotherapy of gastric early-stage marginal zone lymphoma resistant to both anti-Helicobacter pylori antibiotics and chemotherapy. | 1-gen-2009 | Gobbi, Paolo; Corbella, F; Valentino, Francesco; Bergonzi, M; Sangalli, C; Perfetti, V; Corazza, GINO ROBERTO | |
| International prognostic scoring system for Waldenstrom macroglobulinemia. | 1-gen-2009 | Morel, P; Duhamel, A; Gobbi, Paolo; Dimopoulos, Ma; Dhodapkar, Mv; Mccoy, J; Crowley, J; Ocio, Em; Garcia Sanz, R; Treon, Sp; Leblond, V; Kyle, Ra; Barlogie, B; Merlini, Giampaolo | |
| International prognostic scoring system for Waldenstrom macroglobulinemia | 1-gen-2009 | P., Morel; A., Duhamel; Gobbi, Paolo; M. A., Dimopoulos; M. V., Dhodapkar; J., Mccoy; J., Crowley; E. M., Ocio; R., Garcia Sanz; S. P., Treon; V., Leblond; R. A., Kyle; B., Barlogie; Merlini, Giampaolo | |
| Long-term outcome of patients with localized aggressive non-Hodgkin lymphoma treated with ProMECE-CytaBOM plus involved-field radiation therapy: a study of the Gruppo Italiano Studio Linfomi. | 1-gen-2010 | Mannina, D.; Luminari, S.; Dondi, A.; Polimeno, G.; Baldini, L.; Stelitano, C.; Merli, F.; Dell’Olio, M.; Gobbi, Paolo; Giglio, G.; Barbolini, E.; Brugiatelli, M.; Federico, M. | |
| Chemoresistance as a function of the pre-therapy tumor burden and the chemotherapy regimen administered. Differences observed with two current chemotherapy regimens for advanced Hodgkin lymphoma | 1-gen-2011 | Gobbi, Paolo; Valentino, Francesco; Bassi, E.; Coriani, C.; Merli, F.; Bonfante, V.; Marchianò, A.; Gallamini, A.; Bolis, S.; Stelitano, C.; Levis, A.; Federico, M.; Angrilli, F.; Di Giulio, G.; Corazza, GINO ROBERTO | |
| Pamidronate versus observation in asymptomatic myeloma: final results with long follow-up of a randomized study | 1-gen-2011 | D’Arena, G.; Gobbi, Paolo; Broglia, CHIARA MARIA GIOVANNA; Sacchi, S.; Quarta, G.; Baldini, L.; Iannitto, E.; Falcone, A.; Guariglia, R.; Pietrantuono, G.; Villani, O.; Martonelli, M. C.; Mansueto, G.; Sanpaolo, G.; Cascavilla, N.; Musto, P. | |
| Long-term follow-up analysis of HD9601 trial comparing ABVD vs. Stanford V vs. MOPPEBVCAD in patients with newly diagnosed advanced-stage Hodgkin lymphoma. A study from the Intergruppo Italiano Linfomi (IIL). | 1-gen-2011 | Chisesi, T.; Bellei, M.; Luminari, S.; Montanini, A.; Marcheselli, L.; Levis, A.; Gobbi, Paolo; Vitolo, U.; Stelitano, C.; Pavone, V.; Merli, F.; Liberati, M.; Baldini, L.; Bordonaro, R.; Pesce, E. A.; Federico, M. | |
| Improving the AJCC/TNM Classification for use in early gastric cancer | 1-gen-2011 | Gobbi, Paolo; Villano, L.; Pozzoli, D.; Bergonzi, Manuela; Vanoli, Alessandro; Tava, Francesca; Dionigi, Paolo; Corazza, GINO ROBERTO | |
| Tumor burden at diagnosis is the main clinical predictor of cell resistance in patients with early-stage, favorable Hodgkin lymphoma treated with VBM chemotherapy plus radiotherapy. | 1-gen-2012 | Gobbi, Paolo; Bergonzi, Manuela; Bassi, E.; Merli, F.; Coriani, C.; Federico, M. | |
| R-CHOP vs. R-mini-CEOP for the initial treatment of elderly “fit” patients with diffuse large B-cell lymphoma. Results from the ANZINTER3 trial of the Intergruppo Italiano Linfomi (IIL). | 1-gen-2012 | Merli, F.; Luminari, S.; Rossi, G.; Mammi, C.; Marcheselli, L.; Tucci, A.; Ilariucci, F.; Chiappella, A.; Musso, M.; Di Rocco, A.; Stelitano, C.; Alvarez, I.; Baldini, L.; Mazza, P.; Salvi, F.; Arcari, A.; Fragasso, A.; Gobbi, Paolo; Liberati, A. M.; Federico, M. | |
| Tumor burden in Hodgkin's lymphoma can be reliably estimated from a few staging parameters | 1-gen-2012 | Gobbi, Paolo; Bergonzi, E.; Bassi, E.; Merli, F.; Coriani, C.; Stelitano, C.; Iannitto, E.; Federico, M. | |
| Role of glutathione-S-transferase (GST) polymorphisms in patients with advanced Hodgkin lymphoma: results from the HD2000 GISL trial. | 1-gen-2012 | Morabito, F.; Hohaus, S.; Mammi, C.; Marcheselli, L; . Gentile M, .; Merli, F.; Montanini, A.; Stelitano, C.; La Sala, A.; Scalone, R.; Voso, M. T.; Luminari, S.; Iannitto, E.; Gobbi, Paolo; Federico, M. | |
| Tumor burden predicts treatment resistance in patients with early unfavorable or advanced-stage Hodgkin Lymphoma treated with ABVD and radiotherapy. | 1-gen-2012 | Gobbi, Paolo; Bassi, E.; Bergonzi, E.; Merli, F.; Coriani, C.; Iannitto, E.; Luminari, S.; Polimeno, G.; Federico, M. | |
| How I treat enteropathy-associated T-cell lymphoma | 1-gen-2012 | DI SABATINO, Antonio; Biagi, Federico; Gobbi, Paolo; Corazza, GINO ROBERTO | |
| What has happened to VBM (vinblastine, bleomycin and methotrexate) chemotherapy for early-stage Hodgkin lymphoma ? | 1-gen-2012 | Gobbi, Paolo; Federico, M. | |
| Hodgkin lymphoma. | 1-gen-2013 | Gobbi, Paolo; Ferreri, A. J.; Ponzoni, M.; Levis, A. | |
| The prognostic role of time to diagnosis and presenting symptoms in patients with pancreatic cancer | 1-gen-2013 | Gobbi, Paolo; M., Bergonzi; Comelli, MARIO ANGELO; L., Villano; D., Pozzoli; Vanoli, Alessandro; Dionigi, Paolo | |
| Medication prescription and adherence disparities in non valvular atrial fibrillation patients: an Italian portrait from the ARAPACIS study | 1-gen-2014 | Raparelli, Valeria; Proietti, Marco; Buttà, Carmelo; Di Giosia, Paolo; Sirico, Domenico; Gobbi, Paolo; Corrao, Salvatore; Davì, Giovanni; Vestri, Anna Rita; Perticone, Francesco; Corazza, GINO ROBERTO; Violi, Francesco; Basili, Stefania | |
| Tumor burden in Hodgkin’s lymphoma: much more than the best prognostic factor. | 1-gen-2014 | Gobbi, Paolo |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile